08:00 , Dec 9, 2013 |  BC Week In Review  |  Company News

Becton Dickinson sales and marketing update

Becton's BD Diagnostics unit launched its BD Max StaphSR Assay in the U.S. to detect Staphylococcus aureus and methicillin-resistant S. aureus (MRSA). The assay, which has CE Mark approval and is available in Europe,...
07:00 , Sep 9, 2013 |  BC Week In Review  |  Company News

Becton Dickinson sales and marketing update

Becton's BD Diagnostics unit launched its BD Max StaphSR Assay in Europe to detect Staphylococcus aureus and methicillin-resistant S. aureus (MRSA). The assay, which has CE Mark approval, identifies S. aureus and MRSA from...
07:00 , Jul 16, 2012 |  BC Week In Review  |  Clinical News

BD Max MRSA Assay regulatory update

Becton's BD Diagnostics segment said it received FDA clearance for BD Max MRSA Assay to identify patients colonized with methicillin-resistant Staphylococcus aureus (MRSA) from nasal swabs. The in vitro diagnostic, which is performed on the...